INS and obesity due to melanocortin 4 receptor deficiency: Diabetes and obesity were identified as independent risk factors for severe disease with COVID-19.6 Therefore, people with T2D may have made positive behavioural changes promoting weight loss, as seen in other European settings.20,21 The present study found that non-insulin treatment reduced the likelihood of rapid weight gain.